Specificity and Longevity of Antitumor Immune Responses Induced by B7-transfected Tumors

Cancer Research

Volumn 54, Issue 24, 1994, Pages 6477-6483

  Townsend, Sarah E ^a   Su, Fannie W ^a   Atherton, Jeanette M ^a   Allison, James P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CANCER VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; IMMUNE RESPONSE; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOMA; VACCINE PRODUCTION;

ANIMAL; ANTIGENS, CD80; CARCINOMA, SQUAMOUS CELL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLORECTAL NEOPLASMS; FEMALE; FIBROSARCOMA; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOTHERAPY; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MAST-CELL SARCOMA; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, NUDE; NEOPLASM TRANSPLANTATION; SUPPORT, U.S. GOV'T, P.H.S.; THYMOMA;

EID: 0028646191     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Linsley, P.S. Brady, W. Grosmaire, L. Aruffo, A. Damle, N.K. and Ledbetter, J.A. Binding of the B-cell activation antigen B7 to CD28 costimulates T-cell proliferation and interleukin 2 mRNA production. J. Exp. Med. 775: 721-730, 1991.
2. Harding, F. McArthur, J.G. Raulet, D. and Allison, J. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (Lond.), 356: 607-609, 1992.
3. Azuma, M. Cayabyab, M. Buck, D. Phillips, J.H. and Lanier, L.L. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small resting T cells. J. Exp. Med. 775: 353-360, 1992.
4. Azuma, M. Cayabyab, M. Phillips, J.H. and Lanier, L.L. Requirements for CD28-dependent T-cell-mediated cytotoxicity. J. Immunol. 750: 2091-2101, 1993.
5. Harding, F.A. and Allison, J.P. CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177: 1791-1796, 1993.
6. Linsley, P.S. Clark, E.A. and Ledbetter, J.A. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA, 87: 5031-5035, 1990.
7. Gimmi, C.D. Freeman, G.J. Gribben, J.G. Sugita, K. Freedman, A.S. Morimoto, C. and Nadler, L.M. B-cell surface antigen B7 provides a costimulatory siganl that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA, 88: 6575-6579, 1991.
8. Razi-Wolf, Z. Freeman, G.J. Galvin, F. Benacerraf, B. Nadler, L. and Reiser, H. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. USA, 89: 4210-4214, 1992.
9. Freeman, G.J. Gribben, J.G. Boussiotis, V.A. Ng, J.W. Restivo, V.A. Jr. Lombard, L.A. Gray, G.S. and Nadler, L.M. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T-cell proliferation. Science (Washington DC), 262: 909-911, 1993.
10. Freeman, G.J. Borriello, F. Hodes, R.J. Reiser, H. Hathcock, K.S. Laszio, G. McKnight, A.J. Kim, J. Du, L. Lombard, D.B. Gray, G.S. Nadler, L.M. and Sharpe, A.H. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science (Washington DC), 262: 907-909, 1993.
11. Azuma, M. Ito, D. Yagita, H. Okumura, K. Phillips, J.H. Lanier, L.L. and Somoza, C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature (Lond.), 366: 16-1% 1993.
12. Chen, L. Ashe, S. Brady, W.A. Hellström, I. Hellstrom, K.E. Ledbetter, J.A. McGowan, P. and Linsley, P.S. Costimulation of anti-tumor immunity by the B7 counterreceptor for the T-lymphocyte molecules CD28 and CTLA-4. Cell, 77: 1093-1102, 1992.
13. Townsend, S.E. and Allison, J.P. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science (Washington DC), 259: 368-370, 1993.
14. Baskar, S. Ostrand-Rosenberg, S. Nabavi, N. Nadler, L.M. Freeman, G.J. and Glimcher, L.H. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatiblity complex class II molecules. Proc. Natl. Acad. Sci. USA, 90: 5687-5690, 1993.
15. Chen, L. McGowan, P. Ashe, S. Johnston, J. Li, Y. Hellstrom, I. and Hellstrom, K.E. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 779: 523-532, 1994.
16. Donawho, C. and Kripke, M. Immunogenicity and cross-reactivity of syngeneic murine melanomas. Cancer Commun. 2: 101-107, 1990.
17. Miyamoto, S. Sukumar, S. Guzman, R.C. Osborn, R.C. and Nandi, S. Transforming c-ki-ras mutation is a preneoplastic event in mouse mammary carcinogenesis induced in vitro by N-methyl-N-nitrosourea. Mol. Cell. Biol. 10: 1593-1599, 1990.
18. Old, L.J. Boyse, E.A. and Stockert, E. The G (Gross) leukemia antigen. Cancer Res. 25: 813-819, 1965.
19. Allison, J.P. McIntyre, B.W. and Bloch, D. Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. J. Immunol. 729: 2293-2300, 1982.
20. Fidler, I.J. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35: 218-234, 1975.
21. Dialynas, D.P. Quan, Z.S. Wall, K.A. Pierres, A. Quintans, J. Loken, M.R. Pierres, M. and Fitch, F.W. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 757: 2445-2451, 1983.
22. Ledbetter, J.A. and Herzenberg, L.A. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47: 63-90, 1979.
23. Sarmiento, M. Glasebrook, A.L. and Fitch, F.W. IgG or IgM monoclonal antibodies reactive with different determinants of the molecular complex bearing Lyt 2 antigen block T-cell mediated cytolysis in the absence of complement. J. Immunol. 725: 2665-2672, 1980.
24. Ostrand-Rosenberg, S. Thakur, A. and Cements, V. Rejection of mouse sarcoma cells after transfection of MHC class II genes. J. Immunol. 144: 4068-4071, 1990.
25. Mizoguchi, H. O'Shea, J.J. Longo, D.L. Loeffler, C.M. McVicar, D.W. and Ochoa, A.C. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (Washington DC), 258: 1795-1798, 1992.
26. Jung, S. and Schluesener, H.J. Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins. J. Exp. Med. 775: 273-276, 1991.
27. Peace, D.J. Chen, W. Nelson, H. and Cheever, M.A. T-cell recognition of transforming proteins encoded by mutated ras proto-oncogenes. J. Immunol. 146: 2059-2065, 1991.
28. Chen, W. Peace, D.J. Rovira, D.K. You, S.G. and Cheever, M.A. T cell immunity to the joining region of p. 10BCR-ABL. Proc. Natl. Acad. Sci. USA, 89: 1468-1472, 1992.
29. Boon, T. Cerottini, J. Van Den Eynde, B. van der Bruggen, P. and Van Pel, A. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 72: 337-365, 1994.
30. Yu, Y.Y.L. Kumar, V. and Bennett, M. Murine natural killer cells and marrow graft rejection. Annu. Rev. Immunol. 10: 189-213, 1992.
31. Perussia, B. Lymphokine activated killer cells, natural killer cells and cytokines. Curr. Opin. Immunol. 5: 49-55, 1991.
32. Nandi, D. Gross, J. and Allison, J. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 752: 3361-3369, 1994.
33. Gehen, S. Waldner, H. Kundig, T.M. Hengartner, H. and Zinkernagel, R.M. Antivirally protective cytotoxic T-cell memory to LCMV is governed by persisting antigen. J. Exp. Med. 776: 1273-1281, 1992.
34. Moskophidis, D. Lechner, F. Pircher, H. and Zinkernagel, R.M. Virus persistance in acutely infected immunocompetent mice by exhaustion of anti-viral cytotoxic effector T cells. J. Exp. Med. 362: 758-761, 1993.
35. Jamieson, B.D. and Ahmed, R. T cell memory. Long-term persistance of virus-specific cytotoxic T cells. J. Exp. Med. 769: 1993-2005, 1989.
36. Lau, L. Jamieson, B.D. Somasundarum, T. and Ahmed, R. Cytotoxic T cell memory without antigen. Science, 369: 648-652, 1994.